NEPH
NEPHROS INCCompany Information
- Company Name
- NEPHROS INC
- CIK
- CIK0001196298
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NEPH: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- NEPH
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-05-30
- Last sale
- —
- Shares purchased (TTM)
- 79,901
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 5,313,140
- Shares outstanding
- 10,856,541
- Ownership
- 48.94%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- -7.31%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 5 | 4 | 5 | 5 | 5 | 4 | 4 | 2 | 3 | 4 | 4 | 5 | ||||||
| Accounts Receivable Net Current | 4 | 4 | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | ||||||
| Inventory Net | 5 | 4 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 14 | 11 | 11 | 11 | 10 | 9 | 8 | 7 | 8 | 8 | 8 | 9 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Indefinite Lived License Agreements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 16 | 14 | 14 | 13 | 12 | 12 | 11 | 10 | 11 | 11 | 12 | 11 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | ||||||
| Liabilities Current | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | ||||||
| Liabilities | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 3 | 3 | 4 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 154 | 154 | 153 | 153 | 153 | 153 | 153 | 153 | 153 | 153 | 153 | 152 | ||||||
| Retained Earnings Accumulated Deficit | -142 | -143 | -143 | -143 | -144 | -144 | -144 | -145 | -145 | -145 | -144 | -144 | ||||||
| Stockholders Equity | 12 | 11 | 10 | 10 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | ||||||
| Liabilities And Stockholders Equity | 16 | 14 | 14 | 13 | 12 | 12 | 11 | 10 | 11 | 11 | 12 | 11 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | ||||||
| Common Stock Shares Issued | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 10 | ||||||
| Shares Outstanding | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 10 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNEPHROS INC (NEPH) — SEC Financial Statements & Analysis
NEPHROS INC (NEPH) is a surgical & medical instruments & apparatus company, incorporated in DE. NEPHROS INC trades on Nasdaq as: NEPH. NEPHROS INC (NEPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, NEPHROS INC carries a market cap of $38.76M, a P/E ratio of 22.33x, a P/B ratio of 3.24x, a P/S ratio of 1.87x, an enterprise value of $34.06M, and an EV/EBITDA multiple of 19.29x. On profitability, it posts a gross margin of 61.26%, an operating margin of 7.92%, a net margin of 8.38%, a Return on Equity (ROE) of 16.10%, a Return on Assets (ROA) of 12.39%, and a Return on Invested Capital (ROIC) of 26.00%. Per share, it reports EPS of $0.16, diluted EPS of $0.16, free cash flow per share of $-0.06, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 24.20% year-over-year, net income growth of 30.82% year-over-year, and EPS growth of 27.74% year-over-year. On the balance sheet, it maintains a current ratio of 4.07x, a quick ratio of 2.63x, working capital of $10.25M, a debt-to-equity ratio of 0.32x, a debt ratio of 0.24, an interest coverage ratio of 547.33x, free cash flow of $-661.00K (TTM), and net debt of $-4.70M. Figures sourced from SEC EDGAR.
- Market Cap
- $38.76M
- P/E TTM
- 22.33x
- EPS TTM
- $0.16
- P/B TTM
- 3.24x
- ROE TTM
- 16.10%
- ROA TTM
- 12.39%
- Debt To Equity
- 0.32x
- Free Cash Flow TTM
- $-661.00K
- Net Revenue TTM Growth 1Y
- 24.20%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NEPHROS INC in?
NEPHROS INC (NEPH) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does NEPH trade on?
NEPHROS INC (NEPH) trades on the Nasdaq.
Where is NEPHROS INC incorporated?
NEPHROS INC is incorporated in DE.
When was NEPHROS INC (NEPH)'s most recent SEC filing?
NEPHROS INC (NEPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is NEPH's market cap?
NEPHROS INC (NEPH) has a market capitalization of $38.76M as of 2026-06-30.
What is NEPH's P/E ratio?
NEPHROS INC (NEPH)'s trailing twelve month P/E ratio is 22.33x as of 2026-06-30.
What is NEPH's EPS (earnings per share)?
NEPHROS INC (NEPH)'s trailing twelve month EPS is $0.16 as of 2026-06-30.
What is NEPH's ROE (return on equity)?
NEPHROS INC (NEPH)'s trailing twelve month Return on Equity (ROE) is 16.10% as of 2026-06-30.
What is NEPH's ROA (return on assets)?
NEPHROS INC (NEPH)'s trailing twelve month Return on Assets (ROA) is 12.39% as of 2026-06-30.
What is NEPH's ROIC (return on invested capital)?
NEPHROS INC (NEPH)'s trailing twelve month Return on Invested Capital (ROIC) is 26.00% as of 2026-06-30.
What is NEPH's EV/EBITDA?
NEPHROS INC (NEPH)'s trailing twelve month EV/EBITDA is 19.29x as of 2026-06-30.